Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/7809
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mainardes, Rubiana Mara | - |
dc.contributor.author | Khalil, Najeh Maissar | - |
dc.contributor.author | Gremião, Maria Palmira Daflon | - |
dc.date.accessioned | 2014-05-20T13:24:50Z | - |
dc.date.accessioned | 2016-10-25T16:45:29Z | - |
dc.date.available | 2014-05-20T13:24:50Z | - |
dc.date.available | 2016-10-25T16:45:29Z | - |
dc.date.issued | 2010-08-16 | - |
dc.identifier | http://dx.doi.org/10.1016/j.ijpharm.2010.05.020 | - |
dc.identifier.citation | International Journal of Pharmaceutics. Amsterdam: Elsevier B.V., v. 395, n. 1-2, p. 266-271, 2010. | - |
dc.identifier.issn | 0378-5173 | - |
dc.identifier.uri | http://hdl.handle.net/11449/7809 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/7809 | - |
dc.description.abstract | This study describes the preparation and evaluation of biodegradable poly(L-lactide) (PLA) and poly(L, lactide)-poly(ethylene glycol) (PLA-PEG) blend nanoparticles containing zidovudine as model drug. The prepared nanoparticles were characterized in terms of size, zeta potential, morphology and drug entrapment efficiency. The pharmacokinetics of zidovudine following intranasal administration in mice was assessed. The results showed that although PLA and blend nanoparticles had the same morphology, the particle size and zeta potential were changed by the PEG. The drug entrapment efficiency was increased by PEG presence. The pharmacokinetic study showed that all the nanoparticles were able to sustain zidovudine delivery over time, but greater efficiency was obtained with PLA-PEG blend nanoparticles, whose T(max) was twice that of PLA nanoparticles. The PLA and PLA-PEG nanoparticles formulations increased the zidovudine mean half-life by approximately 5.5 and 7 h, respectively, compared to zidovudine aqueous solution. The relative bioavailability of zidovudine-loaded PLA-PEG blend nanoparticles was 2.7, relative to zidovudine-loaded PLA nanoparticles and 1.3 relative to aqueous solution formulation. Thus, the PLA nanoparticles were unable to increase the zidovudine bioavailability compared to aqueous solution formulation. The results obtained in this study indicate the potential of the PLA-PEG blend nanoparticles as carriers for zidovudine delivery by the intranasal route. (C) 2010 Elsevier B.V. All rights reserved. | en |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | - |
dc.format.extent | 266-271 | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier B.V. | - |
dc.source | Web of Science | - |
dc.subject | Nanoparticles | en |
dc.subject | Intranasal administration | en |
dc.subject | Zidovudine | en |
dc.subject | Bioavailability | en |
dc.title | Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles | en |
dc.type | outro | - |
dc.contributor.institution | Universidade Estadual do Centro Oeste (UNICENTRO) | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.description.affiliation | Univ Estadual Ctr Oeste UNICENTRO, Dept Farm, BR-85040080 Guarapuava, PR, Brazil | - |
dc.description.affiliation | Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Farmacos & Medicamentos, BR-14801902 Araraquara, SP, Brazil | - |
dc.description.affiliationUnesp | Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Dept Farmacos & Medicamentos, BR-14801902 Araraquara, SP, Brazil | - |
dc.description.sponsorshipId | FAPESP: 05/50994-6 | - |
dc.identifier.doi | 10.1016/j.ijpharm.2010.05.020 | - |
dc.identifier.wos | WOS:000280212500035 | - |
dc.rights.accessRights | Acesso restrito | - |
dc.relation.ispartof | International Journal of Pharmaceutics | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.